Exploring the Perspective of Lantana camara L. Flowers for Urolithiasis by In Vitro and In Vivo Studies
Article Sidebar
Views | PDF/EPUB Downloads:
107
/ 37
/ 7
Main Article Content
Abstract
Traditional treatments for urolithiasis include pain management and medical interventions like lithotripsy or surgery. Recently, herbal medicines including Lantana camara, have been investigated for their potential antilithiatic properties and as alternative and complementary therapy for urolithiasis. This study aimed to assess the antilithiatic activity of the hydroalcoholic extract and their fractions obtained from Lantana camara L. flowers. The evaluation involved both in vitro and in vivo experiments. In the in vitro assessment, the impact of the extract and its fractions was investigated on several urolithiasis-related processes, including crystal formation, crystal growth, and aggregation. On the other hand, the in vivo evaluation involved the administration of the extract and fractions to rats with induced urolithiasis to study their effects on stone formation, growth, and dissolution. In the nucleation assay, the dichloromethane fraction exhibited the highest calcium oxalate nucleation inhibition with a percentage inhibition of 30.92% at 60 min of incubation. Similarly, in the aggregation assay, the dichloromethane fraction also showed the highest calcium oxalate aggregation inhibition with percentage inhibition of 45.67% at 360 min of incubation. In the in vivo experiment using animal model, the administration of the extract and fractions of Lantana camara L. flowers significantly reduced lithiasis burden, with the dichloromethane fraction demonstrating superior antilithiatic properties. Moreover, the treatment facilitated the dissolution and passage of existing stones. These results highlighted the effectiveness of Lantana camara L. flowers as anti-lithiatic agent, providing scientific evidence for their potential role in the management ofs urolithiasis.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
1. Santhyami S, Laraswati, Agustina L, Agustina P. Exploring Urban Ethnobotany: A Case Study of Medicinal Plants Traded in Gede Hardjonagoro Market, Surakarta, Indonesia. Trop J Nat Prod Res. 2024; 8(4):6839-6852. https://doi.org/10.26538/tjnpr/v8i4.132.
2. Alok S, Jain SK, Verma A, Kumar M, Sabharwal M. Pathophysiology of kidney, gallbladder and urinary stones treatment with herbal and allopathic medicine: A review. Asian Pac J Trop Dis. 2013; 3(6):496 – 504.doi: 10.1016/S2222-1808(13)60107-3.
3. Sohgaura A and Bigoniya P. A review on epidemiology and etiology of renal stone. Am J Drug Discov Dev. 2013: 7(2):54-62. doi: 10.3923/ajdd.2017.54.62.
4. Alelign T and Petros B. Kidney stone disease: an update on current concepts. Adv Urol. 2018; (1):1-12: 3068365.doi: 10.1155/2018/3068365.
5. Kalai R and Sasirekha B. Dietary guidelines to reduce the risk of renal stones. Int J. Nur Edu Res. 2018; 6(1):73-77.doi: 10.5958/2454-2660.2018.00018.2.
6. Xu H, Zisman AL, Coe FL, Worcester EM. Kidney stones: an update on current pharmacological management and future directions.
7. Expert Opin Pharmacother. 2013; 14(4):435-447. doi: 10.1517/14656566.2013.775250.
8. Thongprayoon C, Krambeck AE, Rule AD. Determining the true burden of kidney stone disease. Nat Rev Nephrol. 2020; 16(12):736 –746.
9. York NE, Borofsky MS, Lingeman JE. Risks associated with drug treatments for kidney stones. Expert Opin Drug Safety. 2015; 14(12):1865–1877. doi: 10.1517/14740338.2015.1100604.
10. Sultan S, Aba Umer S, Ahmed B, Naqvi SA, Rizvi SA. Update on surgical management of pediatric urolithiasis. Front Pediatr. 2019; 7:252. doi: 10.3389/fped.2019.00252.
11. Roth RA and Beckmann CF. Complications of extracorporeal shock-wave lithotripsy and percutaneous nephrolithotomy. Urol Clin North Am. 1988; 15(2):155–166.doi:10.1016/S0094-0143(21)01455-5.
12. McAteer JA and Evan AP. The acute and long-term adverse effects of shock wave lithotripsy. Semin Nephrol. 2008; 28(2):200–213. doi: 10.1016/j.semnephrol.2008.01.003.
13. Butterweck V and Khan SR. Herbal medicines in the management of urolithiasis: Alternative or complementary. Planta Med. 2009; 75(10):1095–1103. doi: 10.1055/s-0029-1185719.
14. Kant R, Singh TG, Singh S. Mechanistic approach to herbal formulations used for urolithiasis treatment. Obes Med. 2020; 19:100266. doi: 10.1016/j.obmed.2020.100266.
15. Nimesh S, Ashwlayan VD, Rani R, Prakash O. Advantages of herbal over allopathic medicine in the management of kidney and urinary stones disease. Borneo J Pharm. 2020; 3(3):179–189. doi:10.33084/bjop.v3i3.1415.
16. Kasote DM, Jagtap SD, Thapa D, Khyade MS, Russell WR. Herbal remedies for urinary stones used in India and China: A review. J Ethnopharmacol. 2017; 203:55–68. doi:10.1016/j.jep.2017.03.038.
17. Nirumand MC, Hajialyani M, Rahimi R, Farzaei MH, Zingue S, Nabavi SM, Bishayee A. Dietary plants for the prevention and management of kidney stones: preclinical and clinical evidence and molecular mechanisms. Int J Mol Sci. 2018; 19(3):765. doi: 10.3390/ijms19030765.
18. FazlyBazzaz BS, Darvishi Fork S, Ahmadi R, Khameneh B. Deep insights into urinary tract infections and effective natural remedies. Afr J Urol. 2021; 27(1):1-3. doi: 10.1186/s12301-020-00111-z.
19. Ved A, Arsi T, Prakash O, Gupta A. A review on phytochemistry and pharmacological activity of Lantana camara L. Int J Pharm Sci Res. 2018; 9(1):37-43. doi:10.13040/IJPSR.0975-8232.9(1).37-43.
20. Dhikale R, Gulecha V, Zalte A. The Pharmacognostic Standardisation of Medicinally Important Notorious Weed- Lantana camera. Int J Pharm Sci Nanotechnol. 2022; 15(4):6061–6071.doi: 10.37285/ijpsn.2022.15.4.6.
21. Herbert JM, Maffrand JP, Taoubi K, Augereau JM, Fouraste I, Gleye J. Verbascoside isolated from Lantana camara, an inhibitor of protein kinase C. J Nat Prod. 1991; 54(6):1595–1600. doi: 10.1021/np50078a016
22. Kumar S, Singh B, Yadav A. Ethnobotany and phytochemistry of Lantana camara L. (Verbenaceae). In: Singh B (edition). Botanical Leads for Drug Discovery. Springer, Singapore. 2020. 389-404 p.
23. Ali-Emmanuel N, Moudachirou M, Akakpo JA, Quetin- Leclercq J. Treatment of bovine dermatophilosis with Senna alata, Lantana camara L. and Mitracarpus scaber leaf extracts. J Ethnopharmacol. 2003; 86(2-3):167-171. doi: 10.1016/s0378-8741(03)00054-0.
24. Dubey D and Padhy RN. Antibacterial activity of Lantana camara L. against multidrug resistant pathogens from ICU patients of a teaching hospital. J Herb Med. 2013; 3(2):65– 75. doi: 10.1016/j.hermed.2012.12.002.
25. Tadesse E, Engidawork E, Nedi T, Mengistu G. Evaluation of the anti-diarrheal activity of the aqueous stem extract of Lantana camara Linn (Verbenaceae) in mice. BMC Complement Med. 2017; 17(1):1-8. doi: 10.1186/s12906-017-1696-1.
26. Sathish R, Vyawahare B, Natarajan K. Antiulcerogenic activity of Lantana camara L. leaves on gastric and duodenal ulcers in experimental rats. J Ethnopharmacol. 2011; 134(1):195-197. doi: 10.1016/j.jep.2010.11.049.
27. Vyas N and Argal A. Nephroprotective effect of ethanolic extract of roots and oleanolic acid isolated from roots of Lantana camara L. Int J Pharmacol Clin Scien. 2012; 1(2):54–60. doi: ijphs.org/article/2012/1/2-3.
28. Chandirika JU and Annadurai G. Inhibition of calcium oxalate crystallization in vitro by an extract of Lantana camara L. Int J Creative Res Thoughts. 2018; 6(1): 1188 – 1199. doi:researchgate.net/publication/322925692.
29. Mayee R and Thosar A. Evaluation of Lantana camara L. Linn. (Verbenaceae) for antiurolithiatic and antioxidant activities in rats. Int J Pharm Clin Res. 2011; 3(1):10-14.
30. Abdel-Hady H, El-Sayed MM, Abdel-Hady AA, Hashash MM, Abdel-Hady AM, Aboushousha T, Abdel-Hameed ES, Abdel-Lateef EE, Morsi EA. Nephroprotective Activity of methanolic extract of Lantana camara L. and squash (Cucurbita pepo) on cisplatin-induced nephrotoxicity in rats and identification of certain chemical constituents of Lantana camara L. by HPLC-ESI-MS. Pharmacogn Res. 2018; 10(1):136–147. doi:10.5530/pj.2018.1.24
31. Vyas N and Argal A. Anti-urolithiatic activity of extract and oleanolic acid isolated from the roots of Lantana camara L. on zinc disc implantation induced urolithiasis. Int Sch Res Notices. 2013:1-5. doi: 10.1155/2013/951795.
32. Chatterjee P, Nandy S, Dwivedi A. Nephroprotective effect of methanolic extract of Lantana camara L. against acetaminophen and cisplatin-induced kidney injury. Am J Pharm Tech Res. 2012; 2(2):487-501.
33. Neelima S, Dwarakanadha Reddy P, Kothapalli Bannoth CS. Nephroprotective activity of Annona squamosa leaves against paracetamol-induced nephrotoxicity in rats: In vitro and In vivo experiments. Futur J Pharm Sci. 2020; 6(131):1-8. doi: 10.1186/s43094-020-00149-4
34. Lekouaghet A, Boutefnouchet A, Bensuici C, Gali L, Ghenaiet K, Tichati L. In vitro evaluation of anti-oxidant and anti-inflammatory activities of the hydroalcoholic extract and its fractions from Leuzeaconifera L. roots. S Afr J. Bot. 2020: 132; 103-107. doi: 10.1016/j.sajb.2020.03.042.
35. Dubale S, Kebebe D, Zeynudin A, Abdissa N, Suleman S. Phytochemical screening and antimicrobial activity evaluation of selected medicinal plants in Ethiopia. J Exp Pharmacol. 2023; 15:51-62. doi: 10.2147/JEP. S379805.
36. Fattahi S, Zabihi E, Abedian Z, Pourbagher R, Motevalizadeh Ardekani A, Mostafazadeh A, Akhavan- Niaki H. Total Phenolic and Flavonoid Contents of Aqueous Extract of Stinging Nettle and In Vitro Antiproliferative Effect on Hela and BT-474 Cell Lines. Int J Mol Cell Med. 2014; 3(2):102-7. PMID: 25035860; PMCID: PMC4082812.
37. Hewagama SP and Hewawasam RP. Antiurolithiatic Potential of Three Sri Lankan Medicinal Plants by the Inhibition of Nucleation, Growth, and Aggregation of Calcium Oxalate Crystals In Vitro. Sci World J. 2022; 12:1-13. 8657249. doi: 10.1155/2022/8657249. PMID: 35463824;
PMCID: PMC9019441.
38. Chandra RS. In-vivo and in-vitro models for evaluating anti-urolithiasis activity of herbal drugs. Int J Pharm Sci Res.
2014; 3(5):2277–8713.
39. Patel PK, Patel MA, Vyas BA, Shah DR, Gandhi TR. Antiurolithiatic activity of saponin rich fraction from the fruits of Solanum xanthocarpum Schrad. & Wendl. (Solanaceae) against ethylene glycol induced urolithiasis in rats. J Ethnopharmacol. 2012;144(1):160-70. doi:
10.1016/j.jep.2012.08.043. Epub 2012 Sep 5. PMID: 22981722.
40. Sanders RW. Taxonomy of Lantana sect Lantana (Verbenaceae): II Taxonomic revision. J. Bot Res Inst Tex. 2012; 6: 403–441.
41. Al-Mamoori F, Aburjai T, Al-Tawalbe DM. In-vitro Anti-Nephrolithiatic Activity of Selected Medicinal Plants. Trop J Nat Prod Res. 2022; 6(9):1426-1429. http://www.doi.org/10.26538/tjnpr/v6i9.14.